• İstanbul 16 °C
  • Ankara 9 °C

Pfizer says its COVID-19 pill appears to work against omicron variant

Pfizer says its COVID-19 pill appears to work against omicron variant
Data indicates it will retain robust antiviral activity against current variants of concern, company says

By Ovunc Kutlu

ANKARA (AA) - Pfizer announced Tuesday that its coronavirus candidate pill, PAXLOVID, appears to work against the new omicron variant.

The US pharmaceutical company said recent data "indicates that PAXLOVID will retain robust antiviral activity against current variants of concern."

"Emerging variants of concern, like omicron, have exacerbated the need for accessible treatment options for those who contract the virus, and we are confident that, if authorized or approved, this potential treatment could be a critical tool to help quell the pandemic," it added.

The company said the data is based on final results from an analysis of 2,246 adults enrolled in its phases 2-3 trials of PAXLOVID.

It added that PAXLOVID reduces the risk of hospitalization or death by 88%.


source: News Feed
This news is a total 149 time has been read
UYARI: Küfür, hakaret, rencide edici cümleler veya imalar, inançlara saldırı içeren, imla kuralları ile yazılmamış,
Türkçe karakter kullanılmayan ve büyük harflerle yazılmış yorumlar onaylanmamaktadır.
This news yet comment has been added .
Other News
All Rights Reserved © May 2014 US Muslims | Unauthorized and the resources published.
Haber Scripti: CM Bilişim